The expanding role of fluoroquinolones.

PubWeight™: 1.13‹?› | Rank: Top 10%

🔗 View Article (PMID 12113871)

Published in Am J Med on July 08, 2002

Authors

Anthony J Schaeffer1

Author Affiliations

1: Department of Urology, Northwestern University School of Medicine, Chicago, Illinois 60611-3008, USA.

Articles citing this

Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. Ann Clin Microbiol Antimicrob (2007) 3.07

Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc Natl Acad Sci U S A (2011) 2.21

A small molecule enhances RNA interference and promotes microRNA processing. Nat Biotechnol (2008) 1.80

Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev (2012) 1.55

Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis. Antimicrob Agents Chemother (2009) 1.02

Characterization and its potential application of two esterases derived from the arctic sediment metagenome. Mar Biotechnol (NY) (2008) 1.02

Molecular pathways: microRNAs as cancer therapeutics. Clin Cancer Res (2012) 1.01

Enoxacin inhibits growth of prostate cancer cells and effectively restores microRNA processing. Epigenetics (2013) 0.89

Cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy. Infect Dis Rep (2012) 0.85

Increasing ciprofloxacin resistance among prevalent urinary tract bacterial isolates in Gaza Strip, Palestine. J Biomed Biotechnol (2005) 0.85

Prospective assessment of fluoroquinolone use in a teaching hospital. Eur J Clin Microbiol Infect Dis (2006) 0.85

Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies. BMC Infect Dis (2015) 0.83

Cellulose, chitosan, and keratin composite materials. Controlled drug release. Langmuir (2015) 0.79

Susceptibility pattern of uropathogens to ciprofloxacin at the Ghana police hospital. Pan Afr Med J (2015) 0.78

Alkylation of human hair keratin for tunable hydrogel erosion and drug delivery in tissue engineering applications. Acta Biomater (2015) 0.75